GROUPE BERKEM |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.23 EUR | -3.88% |
|
+2.29% | -27.12% |
| 04-30 | Groupe Berkem Société anonyme Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 02-06 | Givaudan: agreement signed with Berkem | CF |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 44.18M | ||||||
| 728B | ||||||
| 603B | ||||||
| 360B | ||||||
| 332B | ||||||
| 279B |
- Stock Market
- Equities
- ALKEM Stock
- Charts Groupe Berkem
- Sector Chart
